Immunai vs Remepy
Immunai vs Remepy, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Remepy on 57/100.
Where each one leads
Immunai
- our overall score: 69/100 against 57/100
- domain rating: 46/100 against 21/100
- headcount: 179 against 75
- funding raised: $295M against $15.0M
- LinkedIn following: 26,832 against 6,458
Remepy
- agent readiness: 40/100 against 32/100
- headcount growth: +105.6% against +13.0%
At a glance
| Measure | Immunai | Remepy |
|---|---|---|
| What it is | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. | Digital therapeutics platform enhancing drug efficacy and safety through personalized software. |
| Category | Healthcare, Immunology, Data, Analytics | Healthcare, Drug Development, Biotech, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2019 | 2021 |
| Headquarters | New York, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Immunai | Remepy |
|---|---|---|
| Employees | 179 | 75 |
| Headcount growthLast 12 months | +13.0% | +105.6% |
| Total funding | $295M | $15.0M |
| Latest round | Series B | Seed |
| Valuation | $1.0B | Not published |
| LinkedIn followers | 26,832 | 6,458 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunai | Remepy |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 57/100 |
| Traction | 60/100 | 55/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 39/100 | 38/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 21/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunai | Remepy |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager |
Immunai vs Remepy: common questions
Which is better, Immunai or Remepy?
On our 0-100 score Immunai rates higher (69/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Immunai and Remepy compare on the numbers?
Immunai leads on our overall score (69/100 against 57/100), domain rating (46/100 against 21/100), headcount (179 against 75), funding raised ($295M against $15.0M), LinkedIn following (26,832 against 6,458). Remepy leads on agent readiness (40/100 against 32/100), headcount growth (+105.6% against +13.0%).
Read the full Immunai review and pricing or the Remepy review and pricing. You can also browse other Immunai alternatives we track.